2026年4月2日 22:21:44 美国东部夏令时 / 福克斯新闻频道
该公告显示，美国境内分销的专利药品中约53%产自海外
作者：贾斯敏·贝尔 福克斯新闻频道
发布于2026年4月2日 晚上10:21 美国东部夏令时
妮可·萨皮尔博士：“金融毒性”是存在缺陷的医药体系的主要影响
福克斯新闻专栏作家妮可·萨皮尔博士在唐纳德·特朗普总统宣布降低成本的举措后，解释了高药价的危害。
NEW 您现在可以收听福克斯新闻的文章了！
收听本文
3分钟
唐纳德·特朗普总统周四宣布，某些进口专利药品及相关原料将面临最高100%的关税，他将此举定性为国家安全措施，并加大了推动制药业回流美国的力度。
该公告为制药商设立了分级关税制度：获得商务部批准的本土生产计划的公司，关税可降至20%；而部分与政府达成定价和生产协议的企业，可在一定期限内享受零关税待遇。
一名政府高级官员表示，这项政策相当于对海外生产的药品征收“100%的税”。
特朗普的公告称，进口药品和关键原料“以如此规模和条件进口至美国，威胁到美国的国家安全”。
特朗普新关税计划遭多州起诉，或将重回法庭
此举与特朗普的TrumpRx计划（包括TrumpRx.gov网站）相关联。白宫表示，该计划将通过“最惠国”定价协议降低部分昂贵品牌药的价格。（亚历克斯·布兰登/美联社图片）
这一举措将引发围绕品牌药成本和供应的重大冲突。特朗普辩称，美国过度依赖外国制药生产，并为在美国本土设厂的企业提供更低关税。
根据公告，美国境内分销的专利药品中约53%产自海外，而按体积计算，仅15%的专利活性药用原料产自美国本土。
特朗普在国情咨文中推介标志性关税计划，选民反应不一
唐纳德·特朗普总统与美国医疗保险和医疗补助服务中心主任穆罕默德·奥兹博士。（ pooled / 福克斯新闻）
根据该框架，列入附件一的进口专利药品将被征收100%关税，除非符合更低税率的适用条件。
公告显示，获得批准的本土生产计划企业可享受20%的关税，但该税率将在2030年升至100%。
官员们表示，政府正通过这一机制推动企业将生产转移至美国。
特朗普将全球关税上调至15%
特朗普总统一直将降低药价作为其政府的核心议程之一。（ pooled / 福克斯新闻）
公告还为部分盟友设定了更低的关税税率：日本、欧盟、韩国和瑞士的产品适用15%的税率，英国适用10%的税率，未来若达成协议可降至零。
此外，该政策还为同时实现本土生产并与政府达成“最惠国”定价协议的企业开辟了零关税通道。
并非所有药品都会受到影响。公告称，“目前”仿制药不会被征收关税，美国本土生产的药品也不在征税范围内。
这一更大规模的举措与政府的TrumpRx计划相关，包括近期上线的TrumpRx.gov平台。白宫表示，该平台将通过与制药公司达成的“最惠国”定价协议，让美国人能够购买到部分高成本品牌药的低价版本。
点击此处下载福克斯新闻APP
根据公告，部分企业的关税将于2026年7月31日生效，其余企业则于2026年9月29日生效。
特朗普依据1962年《贸易扩张法案》第232条款发布了该命令，该条款允许总统限制被视为威胁国家安全的进口商品。
贾斯敏·贝尔是福克斯新闻数字频道突发新闻撰稿人，报道政治、军事、宗教和文化领域新闻。
Trump slaps up to 100% tariff on some brand-name drug imports in major America First push
2026-04-02 22:21:44 EDT / Fox News
About 53% of patented pharmaceutical products distributed in the US are produced abroad, the proclamation states
By Jasmine Baehr Fox News
Published April 2, 2026 10:21pm EDT
‘Financial toxicity’ is a major effect of the flawed pharmaceutical system, says Dr. Nicole Saphier
Fox News contributor Dr. Nicole Saphier explains the dangers of high pharmaceutical prices after President Donald Trump announced an initiative to lower costs on ‘America Reports.’
NEW You can now listen to Fox News articles!
Listen to this article
3 min
President Donald Trump on Thursday proclaimed that certain imported patented pharmaceuticals and related ingredients could face tariffs of up to 100%, framing the move as a national security measure and intensifying his push to bring drug manufacturing back to the United States.
The proclamation creates a tiered system for drugmakers: companies with Commerce Department-approved plans to onshore production could face a 20% tariff instead, while some firms that strike pricing and manufacturing agreements with the administration could receive zero-tariff treatment for a period.
A senior administration official said the policy amounts to a “100% tax” on drugs produced abroad.
Trump’s proclamation states that imported pharmaceuticals and key ingredients “are being imported into the United States in such quantities and under such circumstances as to threaten to impair the national security of the United States.”
TRUMP’S NEW TARIFF PLAN BARRELS BACK TO COURT FOLLOWING MULTISTATE LAWSUIT
The move ties into Trump’s TrumpRx initiative, including TrumpRx.gov, which the White House says will lower prices on some costly brand-name drugs through “Most-Favored-Nation” pricing deals.(Alex Brandon/AP Images)
The move sets up a major clash over the cost and supply of brand-name medicines, as Trump argues the U.S. is overly dependent on foreign pharmaceutical manufacturing while offering lower tariffs to companies that build in America.
According to the proclamation, about 53% of patented pharmaceutical products distributed in the U.S. are produced abroad, while only 15% of patented active pharmaceutical ingredients by volume are made domestically.
VOTERS REACT AS TRUMP TOUTS SIGNATURE TARIFF PLAN AT STATE OF THE UNION
President Donald Trump with Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz.(Pool / Fox News)
Under the framework, imports of patented pharmaceuticals listed in Annex I will face a 100% tariff, unless they qualify for lower rates.
Companies with approved onshoring plans can instead receive a 20% tariff, though that rate rises to 100% in 2030, according to the proclamation.
The administration is using that structure to push companies to shift production to the United States, officials said.
TRUMP RAISES GLOBAL TARIFF TO 15%
President Trump has made lowering drug prices a major priority of his administration.(Pool / Fox News)
The proclamation also sets lower tariff rates for certain allies: 15% for products from Japan, the European Union (EU), South Korea, and Switzerland, and 10% for the United Kingdom (UK), which could fall to zero under a future agreement.
It also creates a zero-tariff lane for companies that both onshore production and enter “Most-Favored-Nation” pricing agreements with the administration.
Not all drugs are affected. The proclamation says generic pharmaceuticals will not be subject to tariffs “at this time,” and U.S.-origin drugs are also excluded.
The broader push ties into the administration’s TrumpRx initiative, including the recently launched TrumpRx.gov platform, which the White House says gives Americans access to lower prices on some high-cost brand-name drugs through “Most-Favored-Nation” pricing agreements with pharmaceutical companies.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The tariffs will take effect July 31, 2026, for some companies and Sept. 29, 2026, for others, according to the proclamation.
Trump issued the order under Section 232 of the Trade Expansion Act of 1962, which allows the president to restrict imports deemed a national security threat.
Jasmine Baehr is a Breaking News Writer for Fox News Digital, where she covers politics, the military, faith and culture.
发表回复